Statistics
| Views | |
|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 476 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 10 | 6 | 11 | 11 | 13 | 18 | 3 |
| Views | |
|---|---|
| TD_2019_debelder_011.pdf | 611 |
| Views | |
|---|---|
| Argentina | 94 |
| United States | 83 |
| Canada | 38 |
| Peru | 35 |
| Mexico | 25 |
| Spain | 19 |
| Colombia | 13 |
| Ecuador | 11 |
| Chile | 10 |
| Paraguay | 9 |
| Views | |
|---|---|
| Ottawa | 30 |
| Buenos Aires | 26 |
| Lima | 20 |
| Mexico | 11 |
| Federal | 9 |
| Quito | 8 |
| Houston | 7 |
| Menlo Park | 7 |
| San Diego | 7 |
| Vancouver | 7 |